Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kristine Farrar"'
Autor:
Sampa Mukerjee, Devin Leake, Brent E. Korba, Brian H. Johnston, Sergei A. Kazakov, Heini Ilves, Attila A. Seyhan, Kristine Farrar, Roger L. Kaspar, Alexander V. Vlassov
Publikováno v:
Oligonucleotides. 17:223-236
Hepatitis C virus (HCV) is a leading cause of liver cirrhosis and hepatocellular carcinoma worldwide. Currently available treatment options are of limited efficacy, and there is an urgent need for development of alternative therapies. RNA interferenc
Autor:
Marc S. Ayers, Jean-Francois Rossignol, Abigail Beth Montero, Karen Gaye, Kristine Farrar, Sampa Mukerjee, Brent E. Korba
Publikováno v:
Antiviral research. 77(1)
Nitazoxanide (NTZ), a thiazolide anti-infective, is active against anaerobic bacteria, protozoa, and a range of viruses in cell culture models, and is currently in phase II clinical development for treating chronic hepatitis C. In this report, we cha
Publikováno v:
Antiviral research. 65(1)
Alpha, beta, and gamma interferons (IFN-alpha, IFN-beta, IFN-gamma) have been shown to be effective inhibitors of HCV replication in human cell lines carrying HCV replicons. To help define the divergent cellular processes involved in the control of i
shRNAs Targeting Hepatitis C: Effects of Sequence and Structural Features, and Comparison with siRNA
Autor:
Heini Ilves, Attila A. Seyhan, Brian H. Johnston, Brent E. Korba, Sampa Mukerjee, Sergei A. Kazakov, Kristine Farrar, Roger L. Kaspar, Alexander V. Vlassov
Publikováno v:
Antiviral Research. 74:A59-A60
Autor:
Devin Leake, Kristine Farrar, Sampa Mukerjee, Qing Ge, Sergei A. Kazakov, Brent E. Korba, Heini Ilves, Attila A. Seyhan, Brian H. Johnston, Roger L. Kaspar, Alexander V. Vlassov
Publikováno v:
Antiviral Research. 78:A41
Autor:
Alexander V. Vlassov, Brent Korba, Kristine Farrar, Sampa Mukerjee, Attila A. Seyhan, Heini Ilves, Roger L. Kaspar, Devin Leake, Sergei A. Kazakov, Brian H. Johnston
Publikováno v:
Oligonucleotides; Jun2007, Vol. 17 Issue 2, p223-236, 14p